Nanotechnology in Healthcare: Market outlook for applications, tools and materials, and 40 company profiles

Date: January 22, 2010
Pages: 221
Price:
US$ 3,835.00
Publisher: Business Insights
Report type: Strategic Report
Delivery: E-mail Delivery (PDF), Hard Copy Mail Delivery, CD-ROM Mail Delivery
ID: NEAFC1EEC91EN
Leaflet:

Download PDF Leaflet

Nanotechnology in Healthcare: Market outlook for applications, tools and materials, and 40 company profiles
The advent of healthcare nanotechnology has had a vast impact in the fields of drug delivery and diagnostics. The role of nanotechnology in healthcare is very important in terms of eradicating diseases, especially in terms of treating cancer. Advanced technological developments in coatings and implants using nanotechnology is expected to increase the scope of the market in various applications.

This report covers different regional application markets, while evaluating them over the next five years. It provides information about the largest regional markets and factors influencing them, while defining the opportunities they present.

Key features of this report

  • Provides an analysis of market data (revenues) of healthcare nanotechnology applications in North America, Europe, Asia and Rest of World that includes Middle East, Africa, Russia, Latin America and Australia.
  • Studies key market drivers and restraints for the main market and evaluation of respective sub segments with respect to market dynamics.
  • Discusses drug delivery and formulations, biocompatible implants, regenerative medicine and wound care and diagnostics under the applications market along with related sub segments.


  • Scope of this report

  • Understanding the existing and emerging applications of healthcare nanotechnology and their relative and forecast market sizes
  • Understanding the product/technological developments on which the companies are focusing for their growth.
  • Understanding the different nanotechnology based tools and their importance in the development of new products and applications


  • Key Market Issues

  • Nanotechnology initiatives by developing countries are helping in the development of new products and applications.
  • The delay in commercialization due to strict regulations and manufacturing difficulties is inhibiting product reach.
  • Stability of nanoparticles inside the biological tissues is an important issue to be considered to reduce contamination by drugs.
  • The development of biodegradable nanostructures will be a growth driver in future since they eliminate the issue of excretion.


  • Key findings from this report

  • The healthcare nanotechnology market growth is largest in North America, at $4.75bn in 2009, followed by Europe at $3.65.
  • The nanotechnology drug delivery market is expected to grow at a CAGR of 21.7% for the period 2009-14, to reach almost $16bn by 2014.
  • Biocompatible implants and coatings and diagnostics comprise some of the major applications which are estimated to experience high growth between 2009 and 2014, 42% and 21.8% respectively.


  • Key questions answered

  • What are the important healthcare nanotechnology markets and their growth over the period 2009-14?
  • What are the major applications that have emerged in different areas such as drug formulations and delivery, biocompatible implants and coatings, regenerative medicines and wound care and diagnostics?
  • In which areas are the companies focusing while forming strategic alliances with other industry players?


  • Nanotechnology in Healthcare
    Executive summary 16
    Market overview 16
    Healthcare nanotechnology market dynamics 16
    Nanomaterials & nanotools for the healthcare market 17
    Healthcare nanotechnology application market 18
    Company profiles 19

    CHAPTER 1 MARKET OVERVIEW

    Summary 22
    Introduction 23
    Market definition 23
    Healthcare nanotechnology business processes 24
    Healthcare nanotechnology applications 24
    Healthcare nanotechnology application prospects 25
    Opportunity matrix 26
    Challenge matrix 28
    Patent analysis 29

    CHAPTER 2 HEALTHCARE NANOTECHNOLOGY MARKET DYNAMICS

    Summary 34
    Introduction 35
    Regional markets 36
    North America 37
    Europe 38
    Asia 38
    RoW 39
    Competitive landscape 39
    R&D activities by applications 41
    New product launches 42
    Collaborations & agreements 43
    Market drivers 56
    Nanotechnology research initiatives in developing nations 56
    Innovations are increasing 56
    Reduced toxicity 56
    Market inhibitors 57
    Delay in commercialization 57
    Stability and other issues 57
    Need for particle evaluation 57

    CHAPTER 3 NANOMATERIALS & NANOTOOLS FOR THE HEALTHCARE MARKET

    Summary 60
    Introduction 61
    Nanomaterials 61
    Nanocapsules 61
    Drivers 61
    Inhibitors 62
    Opportunities 62
    Nanoporous materials 63
    Drivers 63
    Opportunities 63
    Quantum dots 63
    Drivers 64
    Inhibitors 64
    Opportunities 64
    Nanotubes 65
    Drivers 65
    Nanowires 65
    Drivers 66
    Inhibitors 66
    Opportunities 66
    Dendrimers 67
    Drivers 67
    Opportunities 68
    Monoclonal antibodies 68
    Drivers 68
    Inhibitors 69
    Opportunities 69
    Nanocomposites 69
    Fullerenes 70
    Nanofilms 70
    Drivers 71
    Inhibitors 71
    Opportunities 71
    Nanotools 72
    Nanoarrays 72
    Drivers 72
    Inhibitors 73
    Opportunities 73
    Nanobiochip 74
    Drivers 74
    Opportunities 75
    Nanolithography arrays 75
    Drivers 75
    Inhibitors 76
    Opportunities 76
    Computer-assisted drug discovery 77
    Nanomass spectrometry 77
    Drivers 77
    Inhibitors 78
    Opportunities 78
    Congruent Force Intermolecular Test (nanotype) C-FIT 78

    CHAPTER 4 HEALTHCARE NANOTECHNOLOGY APPLICATION MARKET

    Summary 82
    Introduction 83
    Drug formulation and delivery 83
    Formulation 84
    Drivers 85
    Inhibitors 86
    Opportunities 86
    Fluorescently encoded microparticles 86
    Nanoparticulate formulation/systems 88
    Fluoropolymers as material platforms for drug therapy 88
    DNA nanoparticle technology to produce DNA drugs 89
    Drug profiling using smart materials 90
    Supercritical fluids and water based nanomaterials 91
    Dendrimer nanotechnology products 92
    Potential healthcare nanotechnology drug formulation application 93
    Drug delivery 93
    Drivers 94
    Inhibitors 95
    Opportunities 95
    Nanoencapsulation using nano-device platform 96
    Smart materials for encapsulation 97
    Antimicrobial nanoencapsulation 98
    Nanoscale cochlear drug delivery 99
    Drug delivery using nanoparticles 99
    Nanocrystals for drug delivery 102
    Drug delivery coatings 103
    Nanopores 103
    Nanocomposites 104
    Nanotransponders 105
    Potential applications of healthcare nanotechnology drug delivery 105
    Biocompatible implants and coatings 106
    Drivers 108
    Nanofibers fight immune response 108
    Improvement in biocompatibility 108
    Optimized coatings 108
    Improvement in dental implants 108
    Inhibitors 108
    Improvement of implant depends upon coatings 108
    Possibility of mass poisoning 109
    Opportunities 109
    Improved brain implants 109
    Improvement in process for better coatings 109
    Helpful in orthopedic devices 109
    Surface modification 109
    Device coating 110
    Drivers 112
    Inhibitors 112
    Opportunities 112
    Sol-gel coatings 113
    Biocompatible nanocoatings 113
    Nanoscale plasma coating 113
    Light-activated antimicrobials 113
    Silver nanoparticles 114
    Hydrophobic coatings 114
    Multifunctional coatings 114
    Anti-fouling nanocoatings 114
    Passive hydroxyapatite coating 115
    Other protective coatings 115
    Implants 116
    Drivers 116
    Opportunities 117
    Potential biocompatible implants applications 117
    Life support devices using novel biocompatible polymers 117
    Stimulation electrodes using nanotechnology 117
    Noninvasive killing of cancer cells using localized heat 118
    Artificial vascular grafts 118
    Bone graft substitutes 118
    Regenerative medicine and wound care 118
    Regenerative medicine/tissue engineering 119
    Drivers 120
    Inhibitors 121
    Opportunities 121
    Potential applications of regenerative medicines 123
    Wound care 124
    Drivers 124
    Opportunities 125
    Nanosilver gels 125
    Nanogold gels 125
    Diagnostics 126
    Drivers 127
    Improved bioassays 127
    Earlier diagnosis and effective monitoring 127
    Opportunities 127
    Treatment of ovarian cancer 127
    Development of immunoassays 128
    Quantum dots applications 128
    Nanoemulsions in multimodal molecular imaging and targeted therapeutics 128
    Nanoparticles for biochemical applications 129
    Magnetic nanoparticles for medical diagnostic imaging 129
    Encapsulation of radioactive nanoparticle 129
    Genome sequencing 129
    Nanobiosensors 130
    Nanoarray biochips 130
    Silicon-based chips/sensors for pH and pressure 130
    Micro- and nano-replication for point-of-use analytical applications 131
    Nanocells 131
    Redox enzymes 131
    Other potential diagnostics applications 132
    Smart card diagnostics 132
    Novel microfluidic technologies 132

    CHAPTER 5 COMPANY PROFILES

    Summary 134
    Abraxis BioScience, Inc. 135
    Company overview 135
    Products and services 135
    Company strategy 136
    Access Pharmaceuticals, Inc. 137
    Company overview 137
    Products and services 137
    Company strategy 138
    AstraZeneca 138
    Company overview 138
    Products and services 139
    Company strategy 139
    AMAG Pharmaceuticals, Inc. 139
    Company overview 139
    Products and services 140
    Company strategy 140
    Aphios Corp. 140
    Company overview 141
    Products and services 141
    Company strategy 142
    Asklepios Biopharmaceutical Inc. 142
    Company overview 143
    Products and services 143
    Company strategy 143
    Capsulution Nanoscience AG 144
    Company overview 144
    Products and services 144
    Company strategy 144
    ConvaTec 145
    Company overview 145
    Products and services 145
    Company strategy 146
    Debiotech 146
    Company overview 146
    Products and services 146
    Company strategy 147
    Do-Coop Technologies Ltd. 147
    Company overview 147
    Products and services 147
    Company strategy 148
    Elan Corp. 148
    Company overview 148
    Products and services 148
    Company strategy 149
    Ferro Corp. 149
    Company overview 149
    Products and services 150
    Company strategy 150
    Flamel Technologies 150
    Company overview 151
    Products and services 151
    Company strategy 151
    GE Global Research 152
    Company overview 152
    Company strategy 152
    GfE Medizintechnik GmbH 153
    Company overview 153
    Products and services 153
    Company strategy 154
    HemCon Medical Technologies, Inc. 154
    Company overview 154
    Company strategy 155
    iCeutica Inc 155
    Company overview 155
    Products and services 156
    Company strategy 156
    Liquidia Technologies 157
    Company overview 157
    Company strategy 157
    Luna Innovations Inc. 158
    Company overview 158
    Products and services 158
    Company strategy 159
    MagForce Nanotechnologies AG 159
    Company overview 160
    Products and services 160
    Company strategy 161
    Merck KGaA 161
    Company overview 161
    Products and services 162
    Company strategy 162
    MIV Therapeutics Inc 162
    Company overview 163
    Products and services 163
    Company strategy 163
    Nanomix 163
    Company overview 164
    Products and services 164
    Company strategy 164
    Nano Interface Technology, Inc 165
    Company overview 165
    Products and services 165
    Company strategy 165
    NanoCarrier Co., Ltd. 165
    Company overview 166
    Products and services 166
    Company strategy 166
    NanoDel Technologies 167
    Company overview 167
    Products and services 167
    Company strategy 167
    NanoHorizons Inc. 168
    Company overview 168
    Products and services 168
    Company strategy 168
    Nanoprobes, Inc. 169
    Company overview 169
    Products and services 169
    Company strategy 169
    Nanospectra Biosciences Inc. 170
    Company overview 170
    Products and services 170
    Company strategy 170
    Nanosphere, Inc. 171
    Company overview 171
    Products and services 171
    Company strategy 172
    Novartis AG 172
    Company overview 173
    Products and services 173
    Company strategy 173
    Pfizer 173
    Company overview 173
    Company strategy 174
    PharmaSol GmbH 174
    Company overview 174
    Products and services 174
    Company strategy 175
    Pioneer Surgical Technology 175
    Company overview 175
    Products and services 175
    Company strategy 176
    pSivida 176
    Company overview 176
    Products and services 176
    Company strategy 176
    F. Hoffmann–La Roche Ltd. 177
    Company overview 177
    Products and services 177
    Company strategy 177
    Siemens Medical Solutions 178
    Company overview 178
    Products and services 179
    Company strategy 179
    Smith & Nephew 179
    Company overview 179
    Products and services 180
    Company strategy 180
    Starpharma Holdings Ltd. 181
    Company overview 181
    Products and services 181
    Company strategy 182
    T2 Biosystems Inc. 183
    Company overview 183
    Company strategy 183
    Appendix 184
    Patents 184
    Glossary 218

    LIST OF FIGURES

    Figure 1.1: Global healthcare nanotechnology market 23
    Figure 1.2: Geographical patent share, 2003-08 30
    Figure 1.3: Number of patents by region, 2003-09 30
    Figure 1.4: Comparison of patent trends, 2004 vs 2009 31
    Figure 2.5: Developmental strategies by major players, January 2007–November 2009 40
    Figure 2.6: R&D activities by applications, Jan 2007–Nov 2009 41
    Figure 2.7: New product launches, Jan 2007–Nov 2009 42
    Figure 2.8: Collaborations & agreements by applications, Jan 2007–Nov2009 43
    Figure 2.9: Relative importance of features of healthcare nanotechnology 58

    LIST OF TABLES

    Table 2.1: Global healthcare nanotech market, by geography ($m), 2007-14 37
    Table 2.2: Mergers & acquisitions in healthcare nanotech market, 2007–09 44
    Table 2.3: New product launches in healthcare nanotech market, 2007–09 45
    Table 2.4: New product launches in healthcare nanotech market, 2007–09 (ctd) 46
    Table 2.5: R&D in healthcare nanotech market, 2007–09 47
    Table 2.6: R&D in healthcare nanotech market, 2007–09 (ctd 1) 48
    Table 2.7: R&D in healthcare nanotech market, 2007–09 (ctd 2) 49
    Table 2.8: R&D in healthcare nanotech market, 2007–09 (ctd 3) 50
    Table 2.9: R&D in healthcare nanotech market, 2007–09 (ctd 4) 51
    Table 2.10: R&D in healthcare nanotech market, 2007–09 (ctd 5) 52
    Table 2.11: R&D in healthcare nanotech market, 2007–09 (ctd 6) 53
    Table 2.12: Collaborations & agreements in healthcare nanotech market, 2007–09 54
    Table 2.13: Collaborations & agreements in healthcare nanotech market, 2007–09 (ctd) 55
    Table 4.14: Global healthcare nanotech drug formulation and delivery market, by product ($m), 2007–14 83
    Table 4.15: Global healthcare nanotech drug formulation and delivery market, by geography ($m), 2007–14 84
    Table 4.16: Global healthcare nanotechnology drug formulation market, by product ($m), 2007–14 85
    Table 4.17: Global healthcare nanotech fluorescently encoded microparticles market, by geography ($m), 2007–14 87
    Table 4.18: Global healthcare nanotech nanoparticulate formulation/systems market, by geography ($m), 2007–14 88
    Table 4.19: Global healthcare nanotech fluoropolymers material platforms for drug therapy market, by geography ($m), 2007–14 89
    Table 4.20: Global healthcare DNA nanoparticle technology to produce DNA drugs market, by geography ($m), 2007-14 90
    Table 4.21: Global healthcare nanotech drug profiling using smart materials market, by geography ($m), 2007-14 91
    Table 4.22: Global healthcare nanotech supercritical fluids and water based nanomaterials market, by geography ($m), 2007-14 91
    Table 4.23: Global dendrimer nanotech products market by geography ($m), 2007-14 92
    Table 4.24: Global healthcare nanotech drug delivery market by product ($m), 2007-14 94
    Table 4.25: Global healthcare nanoencapsulation using nano-device platform market, by product ($m), 2007-14 96
    Table 4.26: Global healthcare nanoencapsulation using nano-device platform market, by geography ($m), 2007-14 97
    Table 4.27: Global market for smart materials encapsulating pharmaceuticals, by geography ($m), 2007-14 98
    Table 4.28: Global healthcare nanotech antimicrobial nanoencapsulation, by geography ($m), 2007-14 98
    Table 4.29: Global healthcare nanotech nanoscale cochlear drug delivery, by geography ($m), 2007-14 99
    Table 4.30: Global healthcare nanotech drug delivery using nanoparticles market, by product ($m), 2007-14 100
    Table 4.31: Global healthcare nanotech drug delivery using nanoparticles market, by geography ($m), 2007-14 100
    Table 4.32: Global drug delivery using nanocrystals market, by geography ($m), 2007-14 102
    Table 4.33: Global healthcare nanotech drug delivery coatings market, by geography ($m), 2007- 14 103
    Table 4.34: Global healthcare nanopores market, by geography ($m), 2007-14 104
    Table 4.35: Global healthcare nanocomposites market, by geography ($m), 2007-14 104
    Table 4.36: Global healthcare nanotech nanotransponder market, by geography ($m), 2007-14 105
    Table 4.37: Global healthcare nanotech biocompatible implants and coatings market, by products ($m), 2007-14 107
    Table 4.38: Global healthcare nanotech biocompatible implants and coatings market, by geography ($m), 2007-14 107
    Table 4.39: Global healthcare nanotech surface modification market, by geography ($m), 2007-14 110
    Table 4.40: Global healthcare nanotech device coating market, by products ($m), 2007-14 111
    Table 4.41: Global healthcare nanotech device coating market, by geography ($m), 2007-14 111
    Table 4.42: Global healthcare nanotech implants market, by geography ($m), 2007-14 116
    Table 4.43: Global healthcare nanotech regenerative medicine and wound care market, by products ($m), 2007-14 119
    Table 4.44: Global healthcare nanotech regenerative medicine market, by product ($m), 2007-14 120
    Table 4.45: Global healthcare nanotech wound care market, by products ($m), 2007-14 124
    Table 4.46: Global healthcare nanotech diagnostics market, by products ($m), 2007-14 126
    Table 4.47: Global healthcare nanotech diagnostics market, by geography ($m), 2007-14 127
    Table 0.48: US patents 184
    Table 0.49: US patents (ctd 1) 185
    Table 0.50: US patents (ctd 2) 186
    Table 0.51: US patents (ctd 3) 187
    Table 0.52: US patents (ctd 4) 188
    Table 0.53: US patents (ctd 5) 189
    Table 0.54: US patents (ctd 6) 190
    Table 0.55: US patents (ctd 7) 191
    Table 0.56: US patents (ctd 8) 192
    Table 0.57: US patents (ctd 9) 193
    Table 0.58: US patents (ctd 10) 194
    Table 0.59: US patents (ctd 11) 195
    Table 0.60: US patents (ctd 12) 196
    Table 0.61: US patents (ctd 13) 197
    Table 0.62: US patents (ctd 14) 198
    Table 0.63: US patents (ctd 15) 199
    Table 0.64: US patents (ctd 16) 200
    Table 0.65: US patents (ctd 17) 201
    Table 0.66: US patents (ctd 18) 202
    Table 0.67: US patents (ctd 19) 203
    Table 0.68: Europe patents 204
    Table 0.69: Europe patents (ctd 1) 205
    Table 0.70: Europe patents (ctd 2) 206
    Table 0.71: Europe patents (ctd 3) 207
    Table 0.72: Europe patents (ctd 4) 208
    Table 0.73: Europe patents (ctd 5) 209
    Table 0.74: Europe patents (ctd 6) 210
    Table 0.75: Europe patents (ctd 7) 211
    Table 0.76: Europe patents (ctd 8) 212
    Table 0.77: Europe patents (ctd 9) 213
    Table 0.78: Europe patents (ctd 10) 214
    Table 0.79: Europe patents (ctd 11) 215
    Table 0.80: Japan patents 216
    Table 0.81: Japan patents (ctd 1) 217

    Skip to top


    Ask Your Question

    Nanotechnology in Healthcare: Market outlook for applications, tools and materials, and 40 company profiles
    Company name*:
    Contact person*:
    Phone/fax*:
    Email*:
    Request invoice
    Your enquiry:
    Please click on a Check Box below to confirm you are not a robot: